BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · IEX Real-Time Price · USD
4.570
+0.440 (10.65%)
At close: May 1, 2024, 4:00 PM
4.550
-0.020 (-0.44%)
After-hours: May 1, 2024, 7:56 PM EDT
BioCryst Pharmaceuticals Revenue
In the year 2023, BioCryst Pharmaceuticals had annual revenue of $331.41M with 22.37% growth. Revenue in the quarter ending December 31, 2023 was $93.40M with 17.42% year-over-year growth.
Revenue (ttm)
$331.41M
Revenue Growth
+22.37%
P/S Ratio
2.85
Revenue / Employee
$618,306
Employees
536
Market Cap
942.93M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 331.41M | 60.59M | 22.37% |
Dec 31, 2022 | 270.83M | 113.66M | 72.31% |
Dec 31, 2021 | 157.17M | 139.36M | 782.38% |
Dec 31, 2020 | 17.81M | -31.02M | -63.53% |
Dec 31, 2019 | 48.84M | 28.18M | 136.45% |
Dec 31, 2018 | 20.65M | -4.53M | -18.00% |
Dec 31, 2017 | 25.19M | -1.17M | -4.43% |
Dec 31, 2016 | 26.35M | -21.90M | -45.39% |
Dec 31, 2015 | 48.26M | 34.65M | 254.62% |
Dec 31, 2014 | 13.61M | -3.72M | -21.48% |
Dec 31, 2013 | 17.33M | -8.96M | -34.09% |
Dec 31, 2012 | 26.29M | 6.65M | 33.85% |
Dec 31, 2011 | 19.64M | -42.74M | -68.51% |
Dec 31, 2010 | 62.38M | -12.21M | -16.37% |
Dec 31, 2009 | 74.59M | 18.03M | 31.87% |
Dec 31, 2008 | 56.56M | -14.68M | -20.60% |
Dec 31, 2007 | 71.24M | 65.03M | 1,046.79% |
Dec 31, 2006 | 6.21M | 6.06M | 3,990.38% |
Dec 31, 2005 | 151.87K | -185.03K | -54.92% |
Dec 31, 2004 | 336.90K | -316.35K | -48.43% |
Dec 31, 2003 | 653.26K | - | - |
Dec 31, 2002 | 0 | - | - |
Dec 31, 2001 | 11.16M | 3.50M | 45.64% |
Dec 31, 2000 | 7.66M | 2.33M | 43.77% |
Dec 31, 1999 | 5.33M | -2.30M | -30.12% |
Dec 31, 1998 | 7.63M | 4.93M | 183.23% |
Dec 31, 1997 | 2.69M | 40.36K | 1.52% |
Dec 31, 1996 | 2.65M | 1.77M | 199.82% |
Dec 31, 1995 | 884.59K | 150.77K | 20.55% |
Dec 31, 1994 | 733.82K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
OPKO Health | 863.50M |
Avanos Medical | 673.30M |
Sage Therapeutics | 91.06M |
EyePoint Pharmaceuticals | 46.02M |
Relay Therapeutics | 25.55M |
Mobile-health Network Solutions | 7.87M |
ARS Pharmaceuticals | 30.00K |
BCRX News
- 9 days ago - BioCryst to Report First Quarter 2024 Financial Results on May 6 - GlobeNewsWire
- 14 days ago - BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency - GlobeNewsWire
- 4 weeks ago - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - BioCryst to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones - GlobeNewsWire
- 2 months ago - BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment - GlobeNewsWire
- 2 months ago - BioCryst Launches ORLADEYO® (berotralstat) in Italy - GlobeNewsWire
- 2 months ago - BioCryst to Report Fourth Quarter 2023 Financial Results on February 26 - GlobeNewsWire